ADMA BIOLOGICS INC (ADMA) Stock Balance Sheet
NASDAQ:ADMA • US0008991046
Current stock price
15.15 USD
+0.16 (+1.07%)
At close:
15.1063 USD
-0.04 (-0.29%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 87.63M | 103.15M | 51.35M | 86.50M | 51.10M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 158.43M | 50.00M | 27.42M | 15.50M | 28.60M | |||
| Inventories | 206.47M | 170.24M | 172.91M | 163.30M | 124.70M | |||
| Other Current Assets | 13.99M | 8.03M | 5.33M | 5.10M | 4.30M | |||
| Total Current Assets | 466.51M | 331.41M | 257.01M | 270.40M | 208.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 71.71M | 63.34M | 63.47M | 68.70M | 58.20M | |||
| Goodwill | 3.53M | 3.53M | 3.53M | 3.50M | 3.50M | |||
| Intangibles | 632.00K | 460.00K | 499.00K | 1.00M | 1.70M | |||
| Other Non-Current Assets | 81.86M | 89.94M | 4.67M | 4.80M | 4.10M | |||
| Total Non-Current Assets | 157.73M | 157.27M | 72.17M | 78.10M | 67.60M | |||
| TOTAL ASSETS | 624.24M | 488.68M | 329.18M | 348.50M | 276.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.81M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 28.78M | 29.85M | 31.05M | 24.10M | 16.80M | |||
| Accounts Payable | 22.52M | 20.22M | 15.66M | 13.20M | 12.40M | |||
| Other Current Liabilities | 15.43M | 5.48M | 3.09M | 1.90M | 1.20M | |||
| Total Current Liabilities | 69.54M | 55.54M | 49.81M | 39.30M | 30.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 69.33M | 72.34M | 130.59M | 142.80M | 94.90M | |||
| Other Non-Current Liabilities | 8.05M | 11.78M | 13.58M | 14.40M | 9.80M | |||
| Total Non-Current Liabilities | 77.38M | 84.12M | 144.17M | 157.20M | 104.70M | |||
| TOTAL LIABILITIES | 146.92M | 139.66M | 193.98M | 196.50M | 135.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -161.65M | -308.58M | -506.26M | -478.00M | -412.10M | |||
| Additional Paid In Capital | 671.04M | 657.58M | 641.44M | 630.00M | 553.30M | |||
| Common Shares | 24.00K | 24.00K | 23.00K | 0.00 | 0.00 | |||
| Treasury Stock | -32.09M | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 237.87M | 236.62M | 226.06M | 221.80M | 195.80M | |||
| Tangible Book Value per Share | 1.99 | 1.46 | 0.58 | 0.67 | 0.69 | |||
| Total Shareholders' Equity | 477.32M | 349.02M | 135.21M | 152.00M | 141.20M | |||
| TOTAL LIABILITIES AND EQUITY | 624.24M | 488.68M | 329.18M | 348.50M | 276.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.15 | 0.21 | 0.97 | 0.94 | 0.67 | |||
| Current Ratio | 6.71 | 5.97 | 5.16 | 6.88 | 6.87 | |||
| Return On Assets (ROA) | 23.54% | 40.45% | -8.58% | -18.91% | -25.91% | |||
| Return On Equity (ROE) | 30.78% | 56.64% | -20.89% | -43.36% | -50.71% | |||
| Return On Invested Capital (ROIC) | 27.76% | 25.81% | 7.03% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 32.97% | 33.88% | 8.61% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 33.27% | 34.29% | 8.76% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.20